1. Home
  2. HLI vs BIO Comparison

HLI vs BIO Comparison

Compare HLI & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HLI
  • BIO
  • Stock Information
  • Founded
  • HLI 1972
  • BIO 1952
  • Country
  • HLI United States
  • BIO United States
  • Employees
  • HLI N/A
  • BIO N/A
  • Industry
  • HLI Investment Managers
  • BIO Biotechnology: Laboratory Analytical Instruments
  • Sector
  • HLI Finance
  • BIO Industrials
  • Exchange
  • HLI Nasdaq
  • BIO Nasdaq
  • Market Cap
  • HLI 12.8B
  • BIO 6.0B
  • IPO Year
  • HLI 2015
  • BIO N/A
  • Fundamental
  • Price
  • HLI $185.51
  • BIO $251.56
  • Analyst Decision
  • HLI Buy
  • BIO Strong Buy
  • Analyst Count
  • HLI 7
  • BIO 4
  • Target Price
  • HLI $193.67
  • BIO $324.25
  • AVG Volume (30 Days)
  • HLI 383.9K
  • BIO 407.6K
  • Earning Date
  • HLI 07-29-2025
  • BIO 07-31-2025
  • Dividend Yield
  • HLI 1.29%
  • BIO N/A
  • EPS Growth
  • HLI 41.61
  • BIO N/A
  • EPS
  • HLI 5.82
  • BIO N/A
  • Revenue
  • HLI $2,389,126,000.00
  • BIO $2,541,100,000.00
  • Revenue This Year
  • HLI $10.96
  • BIO N/A
  • Revenue Next Year
  • HLI $11.58
  • BIO $3.49
  • P/E Ratio
  • HLI $31.87
  • BIO N/A
  • Revenue Growth
  • HLI 24.80
  • BIO N/A
  • 52 Week Low
  • HLI $133.48
  • BIO $211.43
  • 52 Week High
  • HLI $192.10
  • BIO $387.99
  • Technical
  • Relative Strength Index (RSI)
  • HLI 68.30
  • BIO 65.86
  • Support Level
  • HLI $176.75
  • BIO $237.42
  • Resistance Level
  • HLI $185.40
  • BIO $254.82
  • Average True Range (ATR)
  • HLI 3.21
  • BIO 7.14
  • MACD
  • HLI 0.68
  • BIO 2.35
  • Stochastic Oscillator
  • HLI 95.76
  • BIO 89.82

About HLI Houlihan Lokey Inc.

Houlihan Lokey Inc is an investment bank with expertise in mergers and acquisitions, capital markets, financial restructuring, valuation, and strategic consulting. The firm serves corporations, institutions, and governments world-wide with offices in the United States, Europe, and the Asia-Pacific region. The company operates in three segments. In the Corporate Finance business segment, it provides M&A and capital markets advisory services. Through the Financial Restructuring business segment, the company advises on some of the complex restructurings around the world. The Financial and Valuation Advisory Services business segment provides valuation and financial opinion, and financial and strategic consulting practices in the United States.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: